Skip to content

Comparison of the effectiveness of clomiphene citrate, tamoxifen and letrozole in ovulation induction

Comparison of the effectiveness of clomiphene citrate, tamoxifen and letrozole in ovulation induction in infertility due to isolated unovulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201104096152N1
Enrollment
150
Registered
2011-06-07
Start date
2007-04-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility associated with anovulation

Interventions

Intervention 1: Group A received clomiphene 50 mg up to 150mg for 5-7days. Treatment starded with minimum dose and effect of drug monitored by sonography. Drugs have been increased in dose and durati
Treatment - Drugs
Group A received clomiphene 50 mg up to 150mg for 5-7days. Treatment starded with minimum dose and effect of drug monitored by sonography. Drugs have been increased in dose and duration to achieve ma
Group B received tamoxifen 10 mg up to 30mg for 5-7days. Treatment starded with minimum dose and effect of drug monitored by sonography. Drugs have been increased in dose and duration to achieve matu
Group C received letrozole 2.5 mg up to 7.5mg for 5-7days. Treatment starded with minimum dose and effect of drug monitored by sonography. Drugs have been increased in dose and duration to achieve ma

Sponsors

Kordestan University of Medical Sciences and Health Services
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: women between 15 to 40 years old with infertility due to unovulation who refer to gynecologists, and they have normal semen analysis, hystrosalpingography and evidence of unovulation (include irregular menses and less than 14 mm folicle in sonography) Exclusion criteria: Abnormal gondothrpins (LH, FSH) and prolactin, clinical finding of hyperandrogenism (including acne and hirsutism) and poly cystic appearance in sonography (including ovarian enlargement and subcoticular multiple small cysts)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Ovulation. Timepoint: monthly. Method of measurement: sonography.

Secondary

MeasureTime frame
Live Birth. Timepoint: after delivery. Method of measurement: postpartum period.;Pregnancy. Timepoint: after missed period. Method of measurement: serum BHCG measurment.;Abortion. Timepoint: monthly in first half of pregnancy. Method of measurement: sonography.;Twin Pregnancy. Timepoint: first prenatal care. Method of measurement: sonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFariba Seyedoshohadaei MD

Besat Hospital -Kurdistan University of Medical Sciences

F.SEYEDOSHOHADAEI@MUK.AC.IR+98 87 1328 2001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026